Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report.

Afshar, Mehdi; Kamstrup, Pia R; Williams, Ken; Sniderman, Allan D; Nordestgaard, Børge G; Thanassoulis, George

Afshar, Mehdi; Kamstrup, Pia R; Williams, Ken; Sniderman, Allan D; Nordestgaard, Børge G; Thanassoulis, George.

Affiliation

Afshar M; From the Department of Medicine, McGill University, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Department of Clinical Biochemistry and The Copenhagen General
Kamstrup PR; From the Department of Medicine, McGill University, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Department of Clinical Biochemistry and The Copenhagen General
Williams K; From the Department of Medicine, McGill University, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Department of Clinical Biochemistry and The Copenhagen General
Sniderman AD; From the Department of Medicine, McGill University, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Department of Clinical Biochemistry and The Copenhagen General
Nordestgaard BG; From the Department of Medicine, McGill University, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Department of Clinical Biochemistry and The Copenhagen General
Thanassoulis G; From the Department of Medicine, McGill University, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Québec, Canada (M.A., A.D.S., G.T.); Department of Clinical Biochemistry and The Copenhagen General

Arterioscler Thromb Vasc Biol ; 36(12): 2421-2423, 2016 Dec.

Article in En | MEDLINE | ID: mdl-27765771

Subject(s)

Aortic Valve Stenosis/prevention & control; Hyperlipoproteinemias/drug therapy; Hypolipidemic Agents/therapeutic use; Lipoprotein(a)/blood; Myocardial Infarction/prevention & control; Aortic Valve Stenosis/diagnosis; Aortic Valve Stenosis/epidemiology; Biomarkers/blood; Denmark/epidemiology; Down-Regulation; Humans; Hyperlipoproteinemias/blood; Hyperlipoproteinemias/diagnosis; Hyperlipoproteinemias/epidemiology; Hypolipidemic Agents/adverse effects; Incidence; Myocardial Infarction/diagnosis; Myocardial Infarction/epidemiology; Prospective Studies; Protective Factors; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

Key words

aortic valve stenosis; atherosclerosis; coronary disease; epidemiology; genetics; lipoproteins; prevention and control

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aortic Valve Stenosis / Lipoprotein(a) / Hyperlipoproteinemias / Myocardial Infarction / Hypolipidemic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Arterioscler Thromb Vasc Biol Journal subject: ANGIOLOGIA Year: 2016 Type: Article

Search on Google

XML

PubMed Links